2004014624

Cat No.
27-159aa
USD 0

Product Information

Product Type
Domain
N
UniProt No.
Recombinant Protein
NCBI Accession No.
ATGP7777
Alternative names
CD160, also known as CD160 antigen, is a human natural killer (NK) -cell-activating receptor that is also expressed on T-cell subsets. It is a tumor-specific antigen known to mediate cellular activation signals in CLL, and is a novel target for therapeutic manipulation and monitoring of minimal residual disease. It was identified as a T cell coinhibitory molecule that interacts with the herpesvirus entry mediator (HVEM) on antigen-presenting cells to deliver a potent inhibitory signal to CD4 (+) T cells. Recombinant human CD160, fused to His-tag at C-terminus, was expressed in insect cell and purified by using conventional chromatography techniques.
Additional Information
Immunology

Product Specification

Molecular Weight
Concentration
CD160 antigen, CD160, BY55, NK1, NK28
Formulation
0.25mg/ml (determined by absorbance at 280nm)
Purity
Farren TW., et al. (2011) Blood. 118:2174-2183.
Bioactivity
> 90% by SDS-PAGE
Endotoxin
15.9 kDa (142aa)
Tag
Applications
Storage
f16 SDSPAGE Comment and Pic

Related Publications

    CD160, CD160 antigen, CD160, BY55, NK1, NK28,ATGP3576-10ug,ATGP3576-20ug,ATGP3576-50ug,ATGP3576-100ug,ATGP3576-250ug,ATGP3576-500ug,ATGP3576-1mg,ATGP3576-10,ATGP3576-20,ATGP3576-50,ATGP3576-100,ATGP3576-250,ATGP3576-500,ATGP3576-1

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.